Introduction Hyperosmolar therapy with mannitol or hypertonic saline (HTS) is the primary medical management strategy for elevated intracranial pressure (ICP). La solución salina isoncótica-hipertónica [NaCl 7,2%/ HES (/0,5) 6%] y manitol (20%), en dosis única con carga osmolar equivalente, fueron efectivos y . isoncótica hipertônica versus manitol (20%) durante neuroanestesia eletiva manitol versus solución isoncótica hipertónica (SIH), durante la neurocirugía.
|Published (Last):||11 January 2008|
|PDF File Size:||16.8 Mb|
|ePub File Size:||4.49 Mb|
|Price:||Free* [*Free Regsitration Required]|
Lazaridis, in a meta-analysis hopertonica inidentified 11 papers on the use of HTS maintains systemic and cerebral haemodynamics. Medical and neurological complications of ischemic stroke: InScalfani et al. Schwartz 33 Estimated H-index: Therefore, in the brain, remains in the vascular fluid compartment and thus removes the intracellular space and intersticial.
The immunomodulatory effects of hypertonic saline resuscitation in patients sustaining traumatic hemorrhagic shock: Malignant manito, edema in patients with hypertensive intracerebral hemorrhage associated with hypertonic saline infusion: Such trials are only necessary if the desig na tion of mannitol as the gold standard is appro-priate and solucjon current evidence suggests its therapeutic equipoise with HTS.
Th is, in turn, will allow the considerable cost and eff ort of large-scale clinical trials to be directed towards questions to which the answers are not already evident.
Research studies that have influenced practice of neuroanesthesiology in recent years: Resuscitation with hypertonic saline-dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients.
Only 1 study out of the 36 articles reviewed found a better long-term result in patients treated with HTS, compared with mannitol. Beneficial effects include improved systemic microcirculation through a reduction of red blood cell and endothelial cell oedema.
This favourable result is associated with improved cerebral tissue oxygenation for more than min. A large prospective randomized study is needed in order to answer this question.
Predictable reduction of intracranial hypertension with hypertonic saline hydroxyethyl starch: Of the 16 hipertpnica reviewed, including 4 prospective randomized studies and multiple observational studies, the data support the use of HTS as an effective means to lower ICP in patients with TBI. Enhancement of cerebral blood flow using systemic hypertonic saline therapy improves outcome in patients with poor-grade spontaneous subarachnoid hemorrhage.
Solucion Hipertonica vs Manitol en HEC
They did not find evidence to support the theory soluckon osmotic agents reduce CBV, arguing against the theory that hipdrtonica reduce ICP by creating cerebral vasoconstriction 89 The AHA guidelines still in force show that osmotherapy is among other aggressive medical measures for the treatment of critically ill patients with malignant cerebral oedema after a large cerebral infarction.
In recent years, hypertonic saline solution has become the most popular osmotic agent for hyperosmolar therapy. Secciones en Hec Ras Documents.
In this article we show the current evidence supporting the use of HTS and mannitol, and examine the question of which of the two agents is considered the best option for the medical treatment of IH.
Many of the problems have not been elucidated yet, hence the need for additional research in order to arrive at a definitive conclusion about the superiority manitil these hyperosmolar agents and for protocols with adequate doses and concentrations of these agents as first-line therapy to control intracranial hypertension.
They concluded that both mannitol and HTS increase CSF osmolality and are associated with equal levels of brain relaxation, arteriovenous O2 difference and lactate during elective craniotomy. Mannitol-induced acute renal failure. In 11 studies, HTS infusion was used and the majority showed it to be effective for ICP control, but only 3 of those studies were prospective and randomized. But it was not untilwhere it is used in the clinic for the first vez. Inthey evaluated these potential complications with HTS and 0.
Together, these two studies [6,7] compile the results of 37 primary investigations, of which 11 represent class I evidence. It is filtered in the glomeruli and reabsorbed wolucion the nephron as an osmotic diuretic, it is hardly metabolized, and it is excreted unchanged. Th e fi rst, a Cochrane review , identifi es four studies supporting the effi cacy of mannitol in treating IH.
Sedimentos en Hec Ras Documents.
Solucion Hipertonica vs Manitol en HEC
Manitol Indicaciones y Contraindicaciones Documents. Hypertoni c saline in critical care: Mannitol for acute traumatic brain injury. Hypertonic saline versus mannitol for the treatment intracranial pressure: J Neuropathol Exp Neurol. Hypertonic saline for treating raised intracranial pressure: Salt or suga r on the brain: HTS produces less osmotic diuresis, thus maintaining hipertoniica stable systemic and cerebral haemodynamics in the neurocritical patient, considering that it does not only lower ICP and maintain CPP, but it also increases PtbO 2.
There was a problem providing the content you requested
The benefit of HTS relative to long-term neurological out-comes compared to that of mannitol is yet unclear. The treatment of tromboangiitis obliterans by intravenous injection of hypertonic salt solution. Weed 15 Estimated H-index: First, barring prohi bitive logistical or cost considerations which do not apply herehipertoonica therapies tend to be the most commonly used treatments for a particular condi-tion.
There are few studies comparing mannitol and HTS in the pure setting of cerebral relaxation in tumours. Dose-response relationship of mannitol and intracranial pressure: Both studies demonstrate the comparative superiority of HTS [6,7], and the meta-analysis quantifi es this eff ect and verifi es its statistical signifi cance . Conflict of interest The authors have no conflicts of interest to declare.
All of the measurements were recorded at the beginning of the study, before treatment, and 15, 30, 60, and min after treatment.